Additional file 1: Table S1. of Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial

Percentage of participants with rSBA antibody titers above the cut-off and GMTs (ATP cohort for persistence Year 5). Table S2. Percentage of participants per age strata with rSBA titers above the cut-off and GMTs (Total Cohort Year 5). Percentage of participants per age strata with rSBA antibody titers ≥1:8 and ≥1:128 and geometric mean titers in the ACWY-TT and the Men-PS groups at pre-vaccination, at Years 4 and 5 (Total Cohort Year 5). (DOC 111 kb